American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S384-S388 , December 2008

The clinical content of preconception care: preconception care for special populations

  • Catherine Ruhl, CNM, MS

      Affiliations

    • Association of Women's Health, Obstetric and Neonatal Nurses, Washington, DC
    • Corresponding Author InformationReprints: Catherine Ruhl, CNM, MS, Association of Women's Health, Obstetric and Neonatal Nurses, 2000L St. NW, Suite 740, Washington, DC 20036
    • ,
  • Barbara Moran, CNM, PhD

      Affiliations

    • Catholic University of America, Washington, DC

Received 17 June 2008 ,Revised 11 September 2008 ,Accepted 18 September 2008.

References 

  1. Thierry J. The importance of preconception care for women with disabilities. Matern Child Health J. 2006;10(Suppl7):175–176
  2. American College of Obstetricians and Gynecologists. Special issues in women's health. Washington, DC: American College of Obstetricians and Gynecologists; 2004;
  3. Kaplan C. Special issues in contraception: caring for women with disabilities. J Midwifery Womens Health. 2006;51:450–456
  4. Smeltzer S. Pregnancy in women with physical disabilities. J Obstet Gynecol Neonatal Nurs. 2007;36:88–96
  5. CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. Recommendations to improve preconception health and healthcare–United States. MMWR Morb Mortal Wkly Rep. 2006;55:1–23
  6. Chevarley F, Thierry J, Gill C, Ryerson A, Nosek M. Health, preventive health care, and health care access among women with disabilities in the 1994-1995 national health interview survey, supplement on disability. Womens Health Issues. 2006;16:297–312
  7. Nosek MA, Howland CA, Young ME. Abuse of women with disabilities: policy implications. J Disabil Policy Stud. 1997;8:157–176
  8. Young ME, Nosek MA, Howland CA, Chanpong G, Rintala DH. Prevalence of abuse of women with physical disabilities. Arch Phys Med Rehabil. 1997;78(Suppl):S34–S38
  9. Cunningham F, Leveno K, Bloom S, Hauth J, Gilstrap L, Wenstrom K. Connective tissue disorders. In: Williams obstetrics. 22nd ed.. New York, NY: McGraw-Hill; 2005;p. 1209–1228
  10. Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48:977–988
  11. American College of Obstetrics and Gynecologists. American College of Obstetricians and Gynecologists (2002) guidelines for women's health care. 2nd ed. Washington, DC. 2002:391-5.
  12. American College of Obstetrics and Gynecologists. American College of Obstetricians and Gynecologists (2002) committee opinion: obstetric management of patients with spinal cord injuries. Number 275. Washington, DC: American College of Obstetricians and Gynecologists.
  13. The Center for Universal Design and the North Carolina Office on Disability and Health. Removing barriers to healthcare: a guide for health professionals (1998). http://www.fpg.unc.edu/∼ncodh/rbar/Accessed Aug. 10, 2007
  14. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. Controlling tuberculosis in the United States. MMWR Morb Mortal Wkly Rep. 2005;54:1–81
  15. Ivey S, Faust S. Immigrant women's health: screening and immunization. West J Med. 2001;175:62–65
  16. US Census Bureau. Current population survey, annual social and economic supplement, 2003. http://www.census.gov/population/socdemo/foreign/ppl-174/tab01-01.pdfAugust 2004;Accessed Oct. 12, 2007
  17. Health Resources and Services Administration. Women's health USA 2005, health status-special populations. http://mchb.hrsa.gov/whusa_05/pages/0431ih.htmAccessed Oct. 12, 2007
  18. US Department of Health and Human Services. Cultural competence. http://www.4women.gov/healthpro/cultural/#immigrantAccessed Oct. 12, 2007
  19. Centers for Disease Control and Prevention. Viral hepatitis B–frequently asked questions. http://www.cdc.gov/Ncidod/diseases/hepatitis/b/acip_faq_fb.htmDecember 2005;Accessed Oct. 17, 2007
  20. National Center for Cultural Competence. Conceptual frameworks/models, guiding values and principles. http://www11.georgetown.edu/research/gucchd/nccc/foundations/frameworks.htmlAccessed Oct. 12, 2007
  21. McEwen MM, Baird M, Pasvogel A, Gallegos G. Health illness transition experiences among Mexican immigrant women with diabetes. Fam Community Health. 2007;30:201–212
  22. Quinn G, Hauser K, Bell-Ellison B, Rodriguez N, Frias J. Promoting pre-conceptional use of folic acid to Hispanic women: a social marketing approach. Matern Child Health J. 2006;10:403–412
  23. Toren A, Rechavi G, Ramot B. Pediatric cancer: environmental and genetic aspects. Pediatr Hematol Oncol. 1996;13:319–331
  24. Lee S, Schover L, Partridge A, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–2931
  25. Schnipper H. Life after breast cancer. J Clin Oncol. 2001;19:3581–3584
  26. The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–1628
  27. Green D, Whitton J, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the childhood cancer survivor study. Am J Obstet Gynecol. 2002;187:1070–1080
  28. Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000;11:161
  29. Green D, Fiorello A, Zevon M, Hall B, Seigelstein N. Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med. 1997;151:379–383
  30. Berry DA, Iversen ES, Gudbjartsson DF, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002;20:2701–2712
  31. Lanier W, Smita B, Eshelman D, et al. Development of risk-based guidelines for pediatric cancer survivors: the children's oncology group long-term follow-up guidelines from the children's oncology group late effects committee and nursing discipline. J Clin Oncol. 2004;22:4979–4990
  32. Shapiro C, Recht A. Drug therapy: side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344:1997–2008
  33. Bar J, Davidi O, Goshen Y, Hod M, Yaniv I, Hirsch R. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol. 2003;189:853–857
  34. Chiarelli AM, Marrett LD, Darlington GA. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol. 1999;150:245–254
  35. Ives A, Saunder C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194
  36. Lipshultz S, Lipsitz S, Sallan S, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002;20:4517–4522
  37. Grady MC. Preconception and the young cancer survivor. Matern Child Health J. 2006;10(Suppl7):165–168

 Conflict of Interest: Catherine Ruhl, CNM, MS; and Barbara Moran, CNM, PhD have no conflict of interest including grants, honoraria, advisory board membership, or share holdings.

PII: S0002-9378(08)01079-X

doi: 10.1016/j.ajog.2008.09.019

American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S384-S388 , December 2008

Article Tools